{"eventGroups":[{"description":"All patients who received Sorafenib treatment.","id":"EG000","otherNumAffected":14,"otherNumAtRisk":14,"seriousNumAffected":9,"seriousNumAtRisk":14,"title":"Treatment (Sorafenib)"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Allergic reaction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":14}],"term":"Anemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Neutrophil count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":14}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":14}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":14}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Weight loss"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Flushing"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Alopecia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":14}],"term":"Rash maculo-papular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":14}],"term":"Palmar-plantar erythrodysesthesia syndro"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Skin and subcutaneous tissue disorders -"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":14}],"term":"Anorexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":14}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":14}],"term":"Diarrhea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Flatulence"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":14}],"term":"Dyspepsia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":14}],"term":"Mucositis oral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Gastrointestinal disorders - Other, spec"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Urinary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Upper respiratory infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":14}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":14}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":14}],"term":"Blood bilirubin increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Musculoskeletal and connective tissue di"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":14}],"term":"Peripheral sensory neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":14}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":14}],"term":"Myalgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Dyspnea"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"White blood cell decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Neutrophil count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":14}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":14}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":14}],"term":"Rash maculo-papular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Palmar-plantar erythrodysesthesia syndro"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Dehydration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":14}],"term":"Diarrhea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Hyponatremia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Generalized muscle weakness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"CTCAE 3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":14}],"term":"Arthralgia"}],"timeFrame":"Assessed every 4 weeks while on treatment and for 30 days after the end of treatment"}